Germline EGFR mutations and familial lung cancer.
Geoffrey R OxnardRuthia ChenJennifer C PharrDiane R KoellerArrien A BertramSuzanne E DahlbergIrene R RainvilleKate P Shane-CarsonKelly A TaylorAlicia Sable-HuntLynette M ShollCraig C TeerlinkAlun ThomasLisa Anne Cannon-AlbrightAndré P FayPatricia Ashton-ProllaHao YangMary M SalvatoreBonnie J AddarioPasi A JanneDavid P CarboneGeorgia L WiesnerJudy E GarberPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
-driver lung adenocarcinomas and lung nodules in germline carriers supports effort to identify affected patients and family members for investigation of CT-based screening for these high-risk individuals.
Keyphrases
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- ejection fraction
- dna repair
- chronic kidney disease
- computed tomography
- peritoneal dialysis
- epidermal growth factor receptor
- magnetic resonance imaging
- prognostic factors
- tyrosine kinase
- early onset
- patient reported outcomes
- contrast enhanced
- dna damage
- dual energy